Cargando…
An unusual case of capecitabine hyperpigmentation: Is hyperpigmentation a part of hand-foot syndrome or a separate entity?
A 59-year-old man with adenocarcinoma of stomach was prescribed capecitabine as adjuvant chemotherapy. After two cycles of therapy, patient developed hyperpigmentation on hands and feet. Examination revealed a peculiar distribution of hyperpigmentation on hands and feet and in addition, hyperpigment...
Autor principal: | Vasudevan, Biju |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2959221/ https://www.ncbi.nlm.nih.gov/pubmed/21206630 http://dx.doi.org/10.4103/0253-7613.70401 |
Ejemplares similares
-
Hyperpigmentation with Capecitabine: Part of Hand-Foot Syndrome or a Separate Entity?
por: Caprez, Jennifer, et al.
Publicado: (2018) -
Imatinib-induced dental hyperpigmentation in chronic myeloid leukemia in an adult female
por: Agrawal, Prabhat, et al.
Publicado: (2015) -
Sorafenib-induced hand-foot syndrome in a patient of renal cell carcinoma
por: Sil, Amrita, et al.
Publicado: (2014) -
Rare occurrence of hand-foot syndrome due to paclitaxel: A rare case report
por: Kataria, Pritam S., et al.
Publicado: (2018) -
A case of capecitabine-induced dermatomyositis
por: Saraswat, Neerja, et al.
Publicado: (2018)